QSAM Biosciences, Inc. Transition report pursuant to Rule 13a-10 or 15d-10

BASIS OF PRESENTATION AND GOING CONCERN (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
BASIS OF PRESENTATION AND GOING CONCERN [Abstract]
Net Ioss	$ 3,536,021	$ 1,612,093
Accumulated deficit	5,365,379	$ 1,829,358
Working capital deficit	$ 2,439,947

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.